CCL11 and Parkinson disease: Although levels of CCL- 11 (eotaxin- 1), a chemokine linked to aging and cognitive decline, are not elevated in PD patients, studies using murine models of PD have demonstrated that neutralizing systemic levels of CCL- 11 and CCL- 5 can protect the nigrostriatal pathway from neurodegeneration [888].